According to study dual expression of MYC and BCL2 is associated with an increased risk of CNS relapse in R-CHOP treated DLBCL patients.
Home / Resource Library / The impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL